ReproCELL Incorporated
4978.T
Get informed when a big investor buys or sells
+ FollowMarket Cap$12.74B
Close$
Share Statistics
| Market cap | $12.74 Billion |
|---|---|
| Enterprise Value | $10.77 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-6.25 |
| Beta | 0.54 |
| Outstanding Shares | 95,675,031 |
Return
| Return on Equity | -4.82% |
|---|---|
| Return on Assets | -4.46% |
| Return on Invested Capital | -9.51% |
Valuation & Multiples
| P/E Ratio | -28.32 |
|---|---|
| PEG | 55.67 |
| Price to Sales | 5.42 |
| Price to Book Ratio | 1.38 |
| Enterprise Value to Revenue | 4.67 |
| Enterprise Value to EBIT | -12.24 |
| Enterprise Value to Net Income | -25 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About ReproCELL Incorporated
101 employees
CEO: Chikafumi Yokoyama Established in 2003 and headquartered in Yokohama, Japan, ReproCELL Incorporated operates as a prominent firm specializing in stem cell research. The company furnishes an extensive portfolio of products crucial for various stem cell appl...